Dow Pharm Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for DOW PHARM, and when can generic versions of DOW PHARM drugs launch?
DOW PHARM has nine approved drugs.
There are two US patents protecting DOW PHARM drugs.
There are five patent family members on DOW PHARM drugs in five countries and eighteen supplementary protection certificates in thirteen countries.
Summary for Dow Pharm
| International Patents: | 5 |
| US Patents: | 2 |
| Tradenames: | 7 |
| Ingredients: | 7 |
| NDAs: | 9 |
| Patent Litigation for Dow Pharm: | See patent lawsuits for Dow Pharm |
Drugs and US Patents for Dow Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dow Pharm | NUTRACORT | hydrocortisone | LOTION;TOPICAL | 080443-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
| Dow Pharm | ALTRENO | tretinoin | LOTION;TOPICAL | 209353-001 | Aug 23, 2018 | RX | Yes | Yes | 11,324,710 | See Plans and Pricing | See Plans and Pricing | ||||
| Dow Pharm | NUTRACORT | hydrocortisone | LOTION;TOPICAL | 087644-001 | Aug 24, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Dow Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Dow Pharm | ATRALIN | tretinoin | GEL;TOPICAL | 022070-001 | Jul 26, 2007 | 5,670,547 | See Plans and Pricing |
| Dow Pharm | ALTRENO | tretinoin | LOTION;TOPICAL | 209353-001 | Aug 23, 2018 | 6,517,847 | See Plans and Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Dow Pharm Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 3095937 | See Plans and Pricing |
| World Intellectual Property Organization (WIPO) | 2019195697 | See Plans and Pricing |
| Brazil | 112020020431 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Dow Pharm Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1304992 | C300617 | Netherlands | See Plans and Pricing | PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322 |
| 0809498 | 10C0038 | France | See Plans and Pricing | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
| 0617614 | 11/2001 | Austria | See Plans and Pricing | PRODUCT NAME: ALITRETINOIN; REGISTRATION NO/DATE: EU/1/00/149/001 20001011 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
